Iovance Biotherapeutics (IOVA)'s 30-day implied volatility (IV30) was 79.4% at the close on November 13, 2026, up from 64.1% the day before, against a 52-week range of 55.3% to 138.5%. Its 20-day historical volatility was 93.1%.
Data as of November 13, 2026.